CJC-1295 in Giv‘at Brenner — GHRH Analog Research Guide
CJC-1295 research guide for Giv‘at Brenner. Covers DAC vs no-DAC forms, half-life differences, purity testing, and how to source quality CJC-1295 for research.
Research-Grade CJC-1295 for Giv‘at Brenner Investigators
For anyone in Giv‘at Brenner searching for CJC-1295, the foundational reality is that this compound is available only through an online research supply market. The practical takeaway for Giv‘at Brenner researchers: sourcing CJC-1295 hinges on vendor quality evaluation, not geography — and the framework for evaluating that quality is the same regardless of where you are. Vendors worth sourcing from make readily available batch-matched Certificates of Analysis showing HPLC chromatograms, mass spec identity confirmation, endotoxin levels, and residual solvent results — all for the specific lot you are purchasing. The sections below cover what Giv‘at Brenner researchers need to know about sourcing, verifying, and handling CJC-1295 for research purposes.
How CJC-1295 Works — Mechanisms & Research
CJC-1295 with DAC (Drug Affinity Complex) is a GHRH analogue with an extended half-life achieved through DAC technology that enables covalent binding to albumin. This modification extends the half-life from minutes (for native GHRH) to approximately 6-8 days, creating a sustained elevation in basal GH levels rather than the pulsatile pattern produced by GHRP compounds. This pharmacokinetic distinction is significant for research design: CJC-1295 based on CJC-1295 with DAC produces a different GH secretion pattern than GHRP compounds, with different downstream effects on IGF-1 and protein synthesis. Researchers in Giv‘at Brenner comparing compounds in this class should account for these pharmacokinetic differences in their experimental design.
How to Source CJC-1295 — Vendor Guide
The first step for any Giv‘at Brenner researcher sourcing CJC-1295 is finding vendors with verified community track records — commercial rankings reflect SEO budgets rather than product quality. The HPLC purity trace is the most important document in the COA: it should show a large primary peak representing CJC-1295, with negligible secondary peaks representing impurities — purity should be 98% or higher. Community reputation in research forums is a useful additional signal to COA verification — vendors with sustained positive community feedback have proved themselves through consistent results. Bacteriostatic water is the appropriate reconstitution medium for CJC-1295 — it contains 0.9% benzyl alcohol that prevents microbial contamination and extends reconstituted shelf life to 4 weeks when kept refrigerated.
Order CJC-1295 — ships to Giv‘at Brenner
COA-verified · International tracking · Research grade
All use of CJC-1295 in Giv‘at Brenner or anywhere is research use only — this compound is not approved for clinical human use, and all handling should follow research laboratory protocols. Lyophilised CJC-1295 should be placed in the freezer at −20°C straight away; repeated freeze-thaw cycles of reconstituted material should be avoided by dividing into single-dose aliquots before freezing. Verify the endotoxin level in your CJC-1295 batch COA before use in any in-vivo protocol — look for results expressed as EU/mg or EU/mL and confirm they fall within appropriate thresholds. Protocol documentation — recording exactly what was used, when, and how — is a research best practice for CJC-1295 that allows any unexpected observations to be properly contextualised.
Frequently Asked Questions
What is the difference between CJC-1295 with DAC and without DAC?
CJC-1295 with DAC uses a lysine-maleimide conjugate to bind covalently to albumin in the bloodstream, extending half-life to ~6-8 days and creating sustained GH elevation. CJC-1295 without DAC (also called Mod GRF 1-29) has a half-life of ~30 minutes and produces acute GH pulses. They produce different GH secretion patterns and have different applications in research.
What purity is required for CJC-1295 research?
CJC-1295 should be ≥98% pure by HPLC. The larger molecular weight of CJC-1295 with DAC (approximately 3647 Da) makes mass spectrometry confirmation particularly important, as impurities may not be obvious on HPLC alone.
What is CJC-1295?
CJC-1295 is a synthetic GHRH (Growth Hormone Releasing Hormone) analogue. The version with DAC (Drug Affinity Complex) has an extended half-life of approximately 6-8 days due to albumin binding. Without DAC, CJC-1295 has a much shorter half-life similar to native GHRH. Both versions stimulate pulsatile GH release via the GHRH receptor.
